Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
- Conditions
- Age Related Macular Degeneration (AMD)
- First Posted Date
- 2022-08-01
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Gyroscope Therapeutics Limited
- Target Recruit Count
- 225
- Registration Number
- NCT05481827
- Locations
- 🇺🇸
Retina Consultants San Diego - Poway, Poway, California, United States
🇺🇸Southwest Retina Research Center, Durango, Colorado, United States
🇺🇸Vitreo Retinal Associates Pa - the Millennium Center Location, Gainesville, Florida, United States
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Gyroscope Therapeutics Limited
- Target Recruit Count
- 255
- Registration Number
- NCT04566445
- Locations
- 🇺🇸
Retinal Research Institute (retina consultants of AZ), Phoenix, Arizona, United States
🇺🇸Retina Vitreous Associates Medical Group, Beverly Hills, California, United States
🇺🇸Retina Consultants of Orange County, Fullerton, California, United States
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2025-09-02
- Lead Sponsor
- Gyroscope Therapeutics Limited
- Target Recruit Count
- 98
- Registration Number
- NCT04437368
- Locations
- 🇺🇸
Retinal Research Institute (retina consultants of AZ), Phoenix, Arizona, United States
🇺🇸Retina Associates of Southern California, Huntington Beach, California, United States
🇺🇸Byers Eye Institute at Stanford, Palo Alto, California, United States
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
- Conditions
- Retinal DiseaseGeographic AtrophyDry Age-related Macular DegenerationMacular DegenerationMacular AtrophyRetinal Degeneration
- First Posted Date
- 2019-03-28
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Gyroscope Therapeutics Limited
- Target Recruit Count
- 83
- Registration Number
- NCT03894020
- Locations
- 🇺🇸
Retinal Research Institute (retina consultants of AZ), Phoenix, Arizona, United States
🇺🇸Retina Centers PC, Tucson, Arizona, United States
🇺🇸Retina Vitreous Associates Medical Group, Beverly Hills, California, United States
FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD
- Conditions
- Macular DegenerationRetinal DegenerationDry Age-related Macular DegenerationEye DiseasesMacular AtrophyRetinal DiseaseGeographic Atrophy
- Interventions
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2025-08-24
- Lead Sponsor
- Gyroscope Therapeutics Limited
- Target Recruit Count
- 56
- Registration Number
- NCT03846193
- Locations
- 🇺🇸
Midwest Eye Institute, Indianapolis, Indiana, United States
🇺🇸Wolfe Eye Clinic, West Des Moines, Iowa, United States
🇺🇸Ophthalamic Consultants of Boston (OCB), Boston, Massachusetts, United States